P.A.W. Capital Corp Regenxbio Inc. Transaction History

P.A.W. Capital Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 10, 2021	SELL	$33.61 - $49.95 $1.34 Million - $2 Million	-40,000 Closed	0 $0
Q4 2020 Feb 11, 2021	SELL	$26.52 - $49.35 $928,200 - $1.73 Million	-35,000 Reduced 46.67%	40,000 $1.81 Million
Q3 2020 Nov 09, 2020	BUY	$27.01 - $40.26 $135,050 - $201,300	5,000 Added 7.14%	75,000 $2.06 Million
Q2 2020 Jul 27, 2020	BUY	$27.75 - $43.44 $555,000 - $868,800	20,000 Added 40.0%	70,000 $2.58 Million
Q1 2020 May 08, 2020	BUY	$21.5 - $54.2 $322,500 - $813,000	15,000 Added 42.86%	50,000 $1.62 Million
Q4 2019 Jan 28, 2020	SELL	$34.54 - $44.87 $1.04 Million - $1.35 Million	-30,000 Reduced 46.15%	35,000 $1.43 Million
Q3 2019 Oct 30, 2019	BUY	$31.84 - $50.88 $1.11 Million - $1.78 Million	35,000 Added 116.67%	65,000 $2.31 Million
Q1 2019 Apr 17, 2019	BUY	$40.82 - $62.45 $1.22 Million - $1.87 Million	30,000 New	30,000 $1.72 Million

196

43M

104K

478K

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $320M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

Get notified when there are updates to the investment portfolio of P.A.W. Capital Corp, based on Form 13F filings with the SEC.

Stay updated on P.A.W. Capital Corp with notifications on news.